Rabbit Polyclonal LINGO2(Center) Antibody

中文名： LINGO2(Center)抗体
别名： Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2, Leucine-rich repeat neuronal protein 3, Leucine-rich repeat neuronal protein 6C, LINGO2, LERN3, LRRN6C

货号: IPDX32313

Price： ￥1180

50μl 100μl

数量：

大包装询价

验证与应用

应用及物种

WB	1/1000	Human,Mouse,Rat
IF	咨询技术	Human,Mouse,Rat
IHC	咨询技术	Human,Mouse,Rat
ICC	技术咨询	Human,Mouse,Rat
FCM	咨询技术	Human,Mouse,Rat
Elisa	咨询技术	Human,Mouse,Rat

产品详情

Aliases	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2, Leucine-rich repeat neuronal protein 3, Leucine-rich repeat neuronal protein 6C, LINGO2, LERN3, LRRN6C
Entrez GeneID	158038
WB Predicted band size	68.1kDa
Host/Isotype	Rabbit IgG
Antibody Type	Primary antibody
Storage	Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species Reactivity	Human
Immunogen	This LINGO2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 393-421 amino acids from the Central region of human LINGO2.
Formulation	Purified antibody in PBS with 0.05% sodium azide.

+ +

LINGO2 Antibody (Center) (Cat. #P32313) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the LINGO2 antibody detected the LINGO2 protein (arrow).

参考文献

以下是关于LINGO2抗体的3篇参考文献示例(注：部分内容为示例性概括，建议结合具体文献原文进一步验证)：

1. **文献名称**: "LINGO2 Antibody Attenuates Axonal Degeneration in a Murine Model of Parkinson’s Disease"

**作者**: Smith J, et al.

**摘要**: 本研究探讨了LINGO2抗体在帕金森病模型中的神经保护作用。实验表明，LINGO2抗体通过抑制LINGO2与受体复合物的相互作用，减少多巴胺能神经元的轴突变性，提示其作为神经退行性疾病治疗策略的潜力。

2. **文献名称**: "Targeting LINGO2 with Monoclonal Antibodies Promotes Oligodendrocyte Differentiation"

**作者**: Lee S, et al.

**摘要**: 该研究开发了一种靶向LINGO2的单克隆抗体，发现其能够促进少突胶质细胞的分化和髓鞘形成。体内实验显示，抗体处理可改善小鼠脊髓损伤后的神经功能恢复，表明LINGO2可能是修复髓鞘损伤的潜在靶点。

3. **文献名称**: "LINGO2 Expression and Antibody Blockade in Glioblastoma Models"

**作者**: Wang Y, et al.

**摘要**: 文章分析了LINGO2在胶质母细胞瘤中的高表达现象，并验证了抗LINGO2抗体对肿瘤细胞增殖的抑制作用。机制研究表明，抗体通过阻断Wnt/β-catenin信号通路抑制肿瘤生长，为癌症免疫治疗提供了新思路。

**注意**：以上文献信息为模拟概括，实际研究中针对LINGO2抗体的直接报道较少(LINGO1研究更为常见)。建议通过PubMed或Web of Science以“LINGO2 antibody”或“LINGO2 function”为关键词检索最新文献，或关注LINGO蛋白家族相关综述以获取背景信息。

背景信息

The LINGO2 (Center) antibody is designed to target the central region of the leucine-rich repeat and immunoglobulin-like domain-containing protein 2 (LINGO2), a transmembrane protein primarily expressed in the central nervous system. LINGO2 belongs to the LINGO family, which includes proteins involved in regulating neuronal survival, axonal guidance, and myelination. While LINGO-1. a well-studied family member, acts as a negative regulator of oligodendrocyte differentiation and myelination via the NgR1/p75/TROY signaling complex, the precise biological role of LINGO2 remains less defined. Emerging evidence suggests its potential involvement in neural development and neurodegenerative disorders, though its signaling mechanisms and interactors are still under investigation.

The LINGO2 (Center) antibody is commonly utilized in research to detect endogenous LINGO2 protein expression in tissues or cell lines, enabling studies on its localization, expression patterns, and functional interactions. Its specificity for the central domain helps avoid cross-reactivity with other LINGO family proteins. Researchers employ this tool in techniques like Western blotting, immunohistochemistry, and immunoprecipitation to explore LINGO2's role in neurological diseases, such as Parkinson’s disease, where genetic variants of LINGO2 have been loosely associated with increased risk. Further applications include elucidating its contribution to neural repair pathways or synaptic plasticity, potentially informing therapeutic strategies for CNS disorders.